-
This Was A 'Profound Victory' For Herbalife
Friday, July 15, 2016 - 10:46am | 332Read More...Following news of Herbalife Ltd. (NYSE: HLF)'s deal with the FTC, Pivotal Research Group’s Timothy S. Ramey maintained a Buy rating and price target of $90, commenting that the deal represents a “profound victory” for the company. According to the deal, Herbalife has agreed...
-
Herbalife Bull: 'A Very Cheap Stock' Ahead Of Q4 Results
Tuesday, February 24, 2015 - 8:25am | 292Read More...Herbalife Ltd. (NYSE: HLF), set to post earnings Thursday, is a "powerfully attractive" stock at its current price, according to a long-time bull. Pivotal Research's Timothy S. Ramey reiterated a Buy and $75 target on the stock Monday and said the company is "clearly a...
-
UPDATE: Pivotal Research Group Initiates Coverage On Constellation Brands
Monday, October 20, 2014 - 3:01pm | 181Read More...Pivotal Research Group initiated a Buy rating on Constellation Brands, Inc. (NYSE: STZ) with $110 price target in a report issued Monday. Analyst Timothy S. Ramey noted the "powerful momentum and growth we see in STZ’s operating sectors – imported beer; premium varietal wines;...
-
Pivotal Research Initiates Coverage On Herbalife, Sees $150 To $200 Price Long-Term
Monday, October 20, 2014 - 1:18pm | 224Read More...Pivotal Research Group initiated coverage of Herbalife Ltd. (NYSE: HLF) with a Buy rating and price target of $110. Analyst Timothy S. Ramey commented that over the long-term he saw potential for the stock to trade at $150 to $200. Ramey believed "that a combination of the negative spin...
-
UPDATE: Pivotal Research Group Initiates Coverage On Nu Skin Enterprises On Positive Outlook
Monday, October 20, 2014 - 8:11am | 187Read More...In a report published Monday, Pivotal Research Group analyst Timothy S. Ramey initiated coverage on Nu Skin Enterprises (NYSE: NUS) with a Buy rating and $75.00 price target. In the report, Pivotal Research Group noted, "Nu Skin Enterprises is a Global Multi-Level Marketer (MLM) of skin care,...
-
D.A. Davidson & Co. Reiterates on Herbalife Ltd. Following Strong Q3 EPS Report
Tuesday, October 29, 2013 - 9:08am | 167Read More...In a report published Tuesday, D.A. Davidson & Co. analyst Timothy S. Ramey reiterated a Buy rating and $92.00 price target on Herbalife Ltd. (NYSE: HLF). In the report, D.A. Davidson & Co. noted, “Herbalife reported Q3 EPS of $1.41, up 36.1% from last year, surpassing our Street-high $1....
-
D.A. Davidson & Co. Reiterates Buy on Herbalife Following Pershing Square Investor Letter
Thursday, October 3, 2013 - 11:25am | 168Read More...In a report published Thursday, D.A. Davidson & Co. analyst Timothy S. Ramey reiterated a Buy rating and $92.00 price target on Herbalife Ltd. (NYSE: HLF). In the report, D.A. Davidson & Co. “According to the October 2, 2013 Pershing Square Investor Letter, Pershing Square has ‘in recent...
-
D.A. Davidson Reiterates Buy Rating on Herbalife Ltd. as Short-Covering Begins
Friday, June 14, 2013 - 8:30am | 155Read More...In a report published Friday, D.A. Davidson analyst Timothy S. Ramey reiterated a Buy rating and $78.00 price target on Herbalife (NYSE: HLF). In the report, D.A. Davidson noted, “Herbalife's short interest, which peaked at 37.2 million shares on December 31st (at a price of $32.94), fell...
-
Reviewing DA Davidson's Bull Call on Herbalife from Yesterday: 'Remains Our Single Best Idea for 2013'
Thursday, June 13, 2013 - 1:09pm | 79Read More...In a report published on Wednesday, D.A. Davidson analyst Timothy S. Ramey reiterated Herbalife (NYSE: HLF) with a rating of Buy and a price target of $78. In the report, D.A. Davidson stated, "The newly-released Nielsen study affirms what we already knew. Herbalife has millions of enthusiastic...
